Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer

Clinical trial NCT01901653 · COMPLETED

Trial details

NCT number: NCT01901653
Sponsor: Stemcentrx
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Small Cell Lung Cancer

Start date: 2013-07-01
Primary completion: 2016-11-28
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.